Increase of activated NK phenotype, defined by CD56+highCD16+, is related to high cytotoxic activity and low cytokine production [19], and its use in allogenic peripheral-blood stem cell transplantation has demonstrated that this T-cell subpopulation can induce tumor regression [20]. Here, NCAM1 is linked to neoplasm.